Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL CRITERIA NETWORK HELP ABOUT

Current criteria:

Regional:

WPRlM journal selection criteria(2023)

Minimum standards for the suspension and removal of WPRIM approved journals

Countries journal selection criteria:

Philippines

Submit your journal information>

Contact NJSCs>

China Oncology

1991  to  Present  ISSN: 1007-3639

Articles

About

Year of publication

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

2058

results

page

of 206

1

Cite

Cite

Copy

Share

Share

Copy

New developments in gastrointestinal stromal tumor

Wen ZHANG ; Jin LI

China Oncology.2000;0(06):-.

Gastrointestinal stromal tumor(GIST) is the most common mesenchymal malignancy of the GI tract. The mainstay of treatment is surgery. For patients in whom complete resection is not possible, or in patients with metastatic or recurrent disease, they are unresponsive to standard chemotherapy and to radiotherapy. There has been no effective systemic treatment for unresectable GIST or metastatic disease. Gain-of-function mutations of the KIT proto-oncogene occur in up to 90% of GIST, allowing constitutive activation of tyrosine kinase (i.e. auto-phosphorylation of tyrosine residues independent of ligand-receptor binding), leading to aberrant cell division and tumour growth. Imatinib selectively inhibits the tyrosine kinase activity associated with KIT, which forms the rationale for evaluating its effects in GIST. Herein, we review recent developments in treatment for GIST and implication for optimal treatment in these patients.

2

Cite

Cite

Copy

Share

Share

Copy

Nedaplatin combined with radiotherapy in the treatment of advanced nasopharyngeal carcinoma

Fei ZHOU ; Jinhong LUO ; Liwei WANG

China Oncology.2000;0(06):-.

0.05). NDP had lower reaction rate, vomiting (15.62%) occurred in NDP group, compared to that which occurred in DDP group (46.88%), with a significant difference between the two groups (P

3

Cite

Cite

Copy

Share

Share

Copy

A randomized clinical study of capecitabine plus oxaliplatin compared with fluorouracil/leucovorin plus oxaliplatin in the treatment of advanced gastric cancer

Shaojun CHEN ; Haixin HUANG ; Guisheng LI

China Oncology.2000;0(06):-.

0.05)。The median time to progression (mTTP)was 5.8 months in XELOX group and 5.7 months in FOLFOX4 group. The median survival time (MST) was 10.0 months in XELOX group and 9.8 months in FOLFOX4 group, The toxicities were well tolerated,The incidence of grade Ⅲ+Ⅳ nausea and vomiting was significantly lower in XELOX group than in FOLFOX4 group (P0.05).Conclusions:Both of the two regimens were feasible, well tolerated and effective in treatment of advanced gastric cancer。XELOX regimen may be safer than FOLFOX4 regimen,especially in elderly patients or patients with ECOG PS of 1 to 2.

4

Cite

Cite

Copy

Share

Share

Copy

Clinical study of video-assisted mini-thoractomy surgery for lung tumor with lymphadenectomy

Jiaming CHE ; Weicheng QIU ; Xiaoqing YANG

China Oncology.2000;0(06):-.

Background and purpose: VATS lobectomy has gained popularity for lung tumor around the world during the recent twenty years.Complete anatomic resections and node dissections are routinely being performed at many centers under VATS, but some thoracic surgeons are concerned regarding the safety, benefit and radical resection of this operative method. Our study was aimed to evaluate the reliability and feasibility of pulmonary resection and lymphadenectomy by video-assisted mini-thoractomy (VAMT) for patients with lung tumor.Methods:From August to September 2006,radical lobectomy or pneumonectomy and systemic lymphadenectomy were performed on 9 patients with lung tumor through video assisted mini-thoracotomy surgery.incidence of complications, total number of dissected lymph nodes,number of metastatic lymph nodes,survival and life quality were evaluated.Results:Totally 100 lymph nodes were removed at average 15.0 minutes, and there was no accident and death happened in the whole operation which only consumed 2.3 hours. Serious postoperative complications and death also did not happen.Conclusions:Video assisted mini-thoracotomy surgery should fulfill the same quality lymphadenectomy and lung tumor definitive resection.

5

Cite

Cite

Copy

Share

Share

Copy

Loop electrosurgical excision procedure for treatment of CINⅢ and cervical carcinoma stage Ⅰ_(A1)

Zhiling ZHU ; Xin LU

China Oncology.2000;0(06):-.

Background and purpose:High frequency loop electrosurgical excision procedure(LEEP)has been widely used in the treatment of cervical intraepithelial neoplasia. The purpose of this study was to explore the value of loop electrosurgical excision procedure in the diagnosis and management of CINⅢ and stage ⅠAl cervical carcinoma.Methods:A retrospective analysis was carried out in 396 cases of CINⅢ and cervical carcinoma with stage ⅠAl undergoing operation and loop electrosurgical excision procedure between January 2003 and October 2006 at Obstetrics and Gynecology Hospital of Fudan University.Results:The coincidence rate of the multiple biopsies before the procedures compared with the conization ones was 88.6 % (351/395). The incidence of residual disease was 10.2%(6/59) and 7.7 % (6/78), respectively in patients with positive margins and negative margins.Conclusions:Loop electrosurgical excision procedure can improve both the diagnosis and treatment of CINⅢ and cervical carcinoma stage ⅠAl. We should offer further treatment properly to the cases with positive margin because of the persistent lesions.

6

Cite

Cite

Copy

Share

Share

Copy

Whether the hepatitis B virus envelope as a gene transfer vector has targeting ability for liver cancer

Dejian PAN ; Donglin WANG ; Zhengtang CHEN

China Oncology.2000;0(06):-.

Background and purpose:The reason for hepatitis B virus (HBV) with hepatocyte specificity is PreS1 enchased on the hepatitis B virus envelope (HBVE). So HBVE may have a potential application in liver targeting gene transfer. In this study, we investigated whether HBVE has the ability to target liver cancer cells. Methods:HBVE was obtained from the supernatant of Hep G 2.2.15 cells through PEG8000 system and ?-propiolactone method. The pIRS2-EGFP was packed with HBVE and resulted in the product HBVE-GFP. HBVE-GFP was transfected into HepG2, A549, HeLa and FB cells. The green fluorescent protein (GFP) expression was observed under a fluorescent microscope. The rate of GFP positive cells was determined by flow cytometer.Results:The GFP could be observed in the four groups, but the HepG2 group had a higher fluorescent intensity than the other 3 groups. The transfected rate of HepG2 group was (71.35?0.03)% , much higher than other groups(P

7

Cite

Cite

Copy

Share

Share

Copy

Comparison of intensity-modulated and three-dimensional conformal techniques for radiotherapy of esophageal carcinoma

Zhiqin JIANG ; Guoliang JIANG

China Oncology.2006;0(07):-.

Three-dimensional conformal radiation therapy(3D-CRT) and intensity-modulated radiation therapy(IMRT) are becoming important parts for research of treatment in esophageal carcinoma patients.The advances of dosimetric study in 3D-CRT,IMRT of esophageal carcinoma and the evaluation indices are reviewed.

8

Cite

Cite

Copy

Share

Share

Copy

Modified three-weeks' docetaxel/cisplatin as first line chemotherapy for advanced non-small cell lung cancer

Shaowei ZHOU ; Haiping ZHANG ; Li WANG

China Oncology.2006;0(07):-.

Background and purpose: Docetaxel/cisplatin are widely used in chemo-naive patients with advanced non-small cell lung cancer(NSCLC),but the standard 3-weeks'project of docetaxel caused significant toxicity.We performed this study to compare the effect and toxicity of modified and standard 3-weeks'docetaxel/cisplatin as first line chemotherapy for advanced NSCLC.Methods:68 patients with stage ⅢB or Ⅳ NSCLC(proven by histology or cytology) were randomly divided into two groups,modified(A) and standard(B) chemotherapy.Group A: docetaxel 75 mg/m2,divided into 2 days,ivgtt d1 and d 8,cisplatin 25 mg/(m2?d),ivgtt d 1-d 3,q3w;Group B: docetaxel 75 mg/m2,ivgtt d 1,cisplatin was administered as Group A,q3w.The effect and toxicity were assessed after two cycles and one-year survival was followed up.Results:There was no CR in both groups.10 PR,20 SD,4 PD were found in group A,the overall response rate is 29%;whereas 11 PR,20 SD,3 PD were found in group B,the overall response rate is 32%.The one-year survival rate were 38% and 35% in group A and B,respectively.There were no significant difference about the overall response rate(P=0.793) and one-year survival rate(P=0.801) between group A and B.The rates of grade Ⅲ/Ⅳ neutropenia were 18% and 47% in group A and B respectively.The difference was statistically significant(P=0.010).Conclusions:In comparison with the standard 3-weeks'docetaxel/ cisplatin chemotherapy,the modified one has similar response rate but lower hematologic toxicity,and thus it was well tolerated.

9

Cite

Cite

Copy

Share

Share

Copy

Influence of MRI on the staging system of 78 patients with nasopharyngeal carcinoma (NPC)

Yucheng LIN

China Oncology.2006;0(07):-.

Background and purpose: The patients with nasopharyngeal carcinoma(NPC) are staged according to Chinese 1992 staging system that is mainly based on clinical symptoms and CT image.Since MRI has been widely used in the clinic,the results were reported to be more accurate than the CT scan.The purpose of this study was to compare the diversity in tumor extension of NPC by computerized tomography(CT) versus magnetic resonance imaging(MRI) and to evaluate if the difference has any impacts on the '92 staging system.Methods:The MRI and CT were taken and compared prior to radiotherapy for 78 cases with histologically proved NPC from Aug.2005 to Aug.2006.Clinical staging was estimated according to '92 staging system based on both of CT or MRI data and clinical information.Results:MRI was significantly superior to CT in the detection of invasion in anterior-styloid space(82.0% vs 65.4%),oropharynx(34.6% vs 20.5%),retropharyngeal lymphatic metastasis(74.4% vs 55.1%),base of skull(51.3% vs 30.8%),cavernous sinus(19.2% vs 5.1%),nasal sinuses(33.3% vs 19.2%) and pterygopalatine fossa(16.7% vs 6.4%.),all the difference showed statistical significance.There were no statistical differences between CT and MRI in the evaluation of involvement of nasal cavity(28.2% vs 21.8%),post-styloid space(65.4% vs 67.9%),pharynx cavity(2.6% vs 1.3%) and cervical lymph node metastasis.According to MRI data,42.3% of T classification,25.6% of N classification,and 28.2% of clinical stages were changed compared to CT scan.Conclusions:There is remarkable advantage of MRI in the detection of infiltration of NPC,especially in the base of skull,cavernous sinus,and retropharyngeal lymphatic metastasis.The '92 stage system should be changed to adapt MRI information into clinical stage and it might impact on the prognosis of NPC.

10

Cite

Cite

Copy

Share

Share

Copy

Prognostic factor analysis of 603 cases with gastric cancer undergoing radical resection

Gang ZHAO ; Jiangfeng QIU ; Zhiyong WU

China Oncology.2006;0(07):-.

0.05).Histological type,gross type,tumor site,lymph node metastasis and depth infiltration were related to the prognosis of gastric cancer(P

Country

China

Publisher

复旦大学附属肿瘤医院

ElectronicLinks

http://www.china-oncology.com

Editor-in-chief

邵志敏

E-mail

zgazzz@china-oncology.com

Abbreviation

China Oncology

Vernacular Journal Title

中国癌症杂志

ISSN

1007-3639

EISSN

Year Approved

2007

Current Indexing Status

Currently Indexed

Start Year

1991

Description

《中国癌症杂志》(ISSN 1007-3639, CN 31-1727/R)1991年创刊,是由中华人民共和国教育部主管、复旦大学附属肿瘤医院主办的全国性肿瘤类、开放获取的学术期刊,月刊。名誉主编为汤钊猷、曹世龙、沈镇宙教授,主编为邵志敏教授。其宗旨是“服务读者,成就作者”。目前,《中国癌症杂志》已被《中文核心期刊要目总览(2020年版)》、中国科学引文数据库(CSCD)(2023—2024 年度)、中国科技论文统计源期刊(中国科技核心期刊)数据库、中文生物医学期刊文献数据库(CMCC)、中国生物医学期刊引文数据库(CMCI)、中国生物文献数据库、《科技期刊世界影响力指数(WJCI)报告(2021年版)》、DOAJ、SCOPUS、EMBASE、《化学文摘》(CA)、EBSCO、JST、Index of Copernicus、《乌利希期刊指南》( Ulrich's Periodical Directory)、GoOA以及WHO西太平洋地区医学索引(WPRIM)等数据库收录。2012年被评为《复旦大学学位与研究生教育国内期刊指导目录》A类期刊。《中国癌症杂志》获首届《CAJ-CD规范》执行优秀奖,2013年度荣获中国抗癌协会系列期刊优胜奖,2016年6月荣获第二届上海市高校优秀科技期刊奖,2017年12月8日获2017年度中国抗癌协会系列期刊优秀论文组织奖,2018年10月21日被评为“2018年度中国高校百佳科技期刊”,2020年12月《中国癌症杂志》“指南与共识”栏目入选2020年华东地区期刊“优秀栏目”,2021年4月荣获第四届上海市高校精品科技期刊奖。2022年11月被评为“2022年度中国高校科技期刊建设示范案例库百佳科技期刊”。《中国癌症杂志》报道内容:主要报道国内外肿瘤学领域前沿的研究内容,包括肿瘤的临床医学、基础医学、流行病学等研究内容。《中国癌症杂志》开设栏目包括:专家述评、论著、综述、论著选登、临床病理讨论、个案报道、指南与共识等。

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.